chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasopharyngitis, Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: On 1/20/2022, I was talking with my boss by phone, and he noticed that my voice sounded different. It sounded like I had a head cold or an allergy. He instructed me to get tested for COVID-19. I contacted our company's safety department, and they made arrangements for me to be tested on 1/21/2022. I underwent a rapid test on 1/21/2022, and the result was positive. I contacted my PCP, and he prescribed me a Flovent HFA inhaler and Tessalon capsules. My symptoms were similar to those of a head cold. I also had a sore throat and a little bit of a cough. I may have also had night sweats one night. All in all, my symptoms lasted about 4 or 5 days and then they were gone. If I hadn't been tested, I would have just thought that I had a mild cold. I was in isolation for 14 days, and during this time, I just worked from home.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Bronchitis, Decreased immune responsiveness, Herpes zoster, Surgery
Clinical narrative: Shingles but 3 months after booster
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Hypotension, Rash, Tachycardia, Throat tightness
Clinical narrative: Anaphylaxis (rash on chest), sensation of throat closing, tachycardia and hypotension.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Basedow's disease, Condition aggravated, Muscular weakness
Clinical narrative: Grave's disease since last year (diagnosed after 2nd dose). Muscle weakness recently after 3rd dose. Both still occurring.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Nausea, Pyrexia
Clinical narrative: Symptoms: nausea; dizziness; SOB, hx of COPD and cardiac problems, taking meds frequently, had to take more often last night, unknown if SOB is worse than baseline currently; pt feeling better; fever, no thermometer
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Asthma, COVID-19, Condition aggravated, Cough
Clinical narrative: About 2.5 months after vaccination, I started feeling very tired and had a lot of coughing. I had no energy for several weeks. I was taking my nebulizer at least every 3-4 hours. I tried taking OTC Sudafed. I ended up with a sinus infection. Starting the second week, I called my doctor and I was started on Azithromycin. It helped slightly but my asthma was still out of control. After almost 2 weeks, I ended up having to call my allergist and he prescribed me two different rounds of prednisone before my asthma started getting better. I was sick for a month. I tested positive for Covid 6 months after 3rd vaccine.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Malaise, SARS-CoV-2 test positive, Sinusitis
Clinical narrative: About 2.5 months after vaccination, I started feeling very tired and had a lot of coughing. I had no energy for several weeks. I was taking my nebulizer at least every 3-4 hours. I tried taking OTC Sudafed. I ended up with a sinus infection. Starting the second week, I called my doctor and I was started on Azithromycin. It helped slightly but my asthma was still out of control. After almost 2 weeks, I ended up having to call my allergist and he prescribed me two different rounds of prednisone before my asthma started getting better. I was sick for a month. I tested positive for Covid 6 months after 3rd vaccine.
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Fatigue, Injection site erythema, Injection site pain, Injection site warmth, Pyrexia
Clinical narrative: Patient experienced fever and fatigue 24 hours after. She self-medicated with over-the-counter Tylenol. She also had redness on her arm near the injection site (approximately 4 inches wide). It was warm to the touch but not itchy or painful at the time of the visit. She previously states that it was sore days after the injection .
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Rash papular, Urticaria
Clinical narrative: Pt. vaccinated at 3:40 pm.  Approx 5 minutes after mom reports slight raised hives to left neck.  Assessed patient, small area of hives noted.  Pt. denies itchy or SOB or throat tightness.  VS:  BP 120/76  HR 89  O2 Sat:  99%  RR 14  Assessed patient every 5- 10 minutes.  Vitals: WNL  Lead nurse notified and Clinic Manager.  Asked mom if ok to give Benedryl. Same given per facility protocol 25 mg PO.  Monitored pt.  VS:  416 pm  BP 104/70  HR 92  O2Sat 98%.  Hives to left neck cleared.  Advised mom if s/s persist or worsen to seek professional medical care and to make appt. with primary care re:  allergic reation.  Advised pt. to drink plenty of H20 DC to home with mom.  Denies S/S
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 13 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 27 days before the administration. There were no adverse reactions reported after the administration.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. No adverse reactions reported after the administration. Pfizer provided temperature excursion data to determine the vaccine was still viable.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 3 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for a few hours before the administration. There were no adverse reactions reported after the administration.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy kept the vaccine in the freezer (average temperature at -23.9 C) for 27 days before the administration. No adverse reactions reported after the administration.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 27 days before the administration. There were no adverse reactions reported after the administration.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness, Throat tightness
Clinical narrative: Patient was instructed to wait 30 minutes, but left after 15 minutes, returned to clinic with c/o squeezing in the throat and neck. Was red and hot in appearance. Emergency was called, epi and diphenhydramine was administered.  Transported via ambulance to local ER, was able to ambulate to transport vehicle.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 1 day before the administration. There were no adverse reactions reported after the administration.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of PFIZER gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 13 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for a few hours before the administration. There were no adverse reactions reported after the administration.
Age: 17.0
Sex: F
Vaccine: HEP
Symptoms: Neuropathy peripheral
Clinical narrative: Sudden onset of neuropathy symptoms approximately 24 hours after the vaccine, which persisted for 3 weeks
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 27 days before the administration. There were no adverse reactions reported after the administration.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for a few hours before the administration. There were no adverse reactions reported after the administration.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 1 day before the administration. There were no adverse reactions reported after the administration.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 27 days before the administration. There were no adverse reactions reported after the administration.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Cardiac monitoring, Cardiac murmur, Cardiac stress test, Chest pain
Clinical narrative: Allergy shot reaction the next day causing mold poisoning. I had chest pains, a hard time breathing, poor circulation, fatigue, and a heart murmur that last for months. Still recovering but much better.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram thorax, Dyspnoea, Echocardiogram, Exposure to fungus, Fatigue
Clinical narrative: Allergy shot reaction the next day causing mold poisoning. I had chest pains, a hard time breathing, poor circulation, fatigue, and a heart murmur that last for months. Still recovering but much better.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Immune system disorder, Injection related reaction, Mycotoxicosis, Poor peripheral circulation
Clinical narrative: Allergy shot reaction the next day causing mold poisoning. I had chest pains, a hard time breathing, poor circulation, fatigue, and a heart murmur that last for months. Still recovering but much better.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray
Clinical narrative: Allergy shot reaction the next day causing mold poisoning. I had chest pains, a hard time breathing, poor circulation, fatigue, and a heart murmur that last for months. Still recovering but much better.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 1 day before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 10 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for a few hours before the administration. There were no adverse reactions reported after the administration.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 13 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 38 days before the administration. There were no adverse reactions reported after the administration.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pain in extremity, Rheumatoid arthritis, Spondylitis
Clinical narrative: At the time of the shot, I just had increased fatigue.  However, I believe the shot has caused a severe case of rheumatoid arthritis as I had an intense flare-up of severe pain in every joint for nearly 2 months, starting in February.  I have joint pain in my knuckles, wrists, elbows, hips, knees, feet, etc.  I am in the process of changing Medicaid providers and establishing a new primary care doctor.  The bulk of my medical records are with the Health Department.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray abnormal
Clinical narrative: At the time of the shot, I just had increased fatigue.  However, I believe the shot has caused a severe case of rheumatoid arthritis as I had an intense flare-up of severe pain in every joint for nearly 2 months, starting in February.  I have joint pain in my knuckles, wrists, elbows, hips, knees, feet, etc.  I am in the process of changing Medicaid providers and establishing a new primary care doctor.  The bulk of my medical records are with the Health Department.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 13 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 27 days before the administration. There were no adverse reactions reported after the administration.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 1 day before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 1 day before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: Upon the delivery of Pfizer gray cap vaccine on 2/15/2022, pharmacy has kept the vaccine in the freezer (average temperature at -23.9 C) for 13 days before the administration. There were no adverse reactions reported after the administration. Pfizer has provided temperature excursion data to determine that the vaccine was still viable.
Age: 42.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site swelling
Clinical narrative: PATIENT EXPERIENCED SWELLING AT SITE OF INJECTION
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Diuretic therapy, Dysuria, Fluid retention
Clinical narrative: Within 6 hours of vaccine, I experienced marked fluid retention and difficulty urinating. Within 14 hours of vaccine, fluid retention became visually evident - hands, ankles, legs, feet and abdomen. Also extreme aches in joints especially hands and shoulders.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Renal function test
Clinical narrative: Within 6 hours of vaccine, I experienced marked fluid retention and difficulty urinating. Within 14 hours of vaccine, fluid retention became visually evident - hands, ankles, legs, feet and abdomen. Also extreme aches in joints especially hands and shoulders.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Feeling abnormal, Feeling cold, Immunisation reaction
Clinical narrative: Male and I got our second shots (Moderna) yesterday about 3:00 p.m.  By that evening I was feeling "off."  When I went to bed I began to experience constant severe chills.  I put on more pajamas, warm socks, and extra blankets.  No improvement.  I slept fitfully, shivering with cold in a room that was 74 degrees.  I finally got up around 4:00 a.m. and took my temperature.  Normal.  I began to have diarrhea and in a few minutes, I was nauseous and began vomiting.  It was a rough night, and I just assumed I had picked up some intestinal bug.  I happened to have an appointment today with a new doctor I am trying out to replace my former primary care doctor.  The moment I mentioned my symptoms, he said it was the COVID booster.  He has a specialty for geriatric patients and has seen this already.  His own mother had the same reaction to her second booster shot.  Naturally, male had no trouble at all!
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Sleep disorder, Vomiting
Clinical narrative: Male and I got our second shots (Moderna) yesterday about 3:00 p.m.  By that evening I was feeling "off."  When I went to bed I began to experience constant severe chills.  I put on more pajamas, warm socks, and extra blankets.  No improvement.  I slept fitfully, shivering with cold in a room that was 74 degrees.  I finally got up around 4:00 a.m. and took my temperature.  Normal.  I began to have diarrhea and in a few minutes, I was nauseous and began vomiting.  It was a rough night, and I just assumed I had picked up some intestinal bug.  I happened to have an appointment today with a new doctor I am trying out to replace my former primary care doctor.  The moment I mentioned my symptoms, he said it was the COVID booster.  He has a specialty for geriatric patients and has seen this already.  His own mother had the same reaction to her second booster shot.  Naturally, male had no trouble at all!
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes not going down; only getting bigger.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Movement disorder
Clinical narrative: Bell's palsy - loss of ability to move right side of face beginning approximately 3 weeks after vaccine booster. Started course of treatment with steroids and antiviral medication.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arrhythmia, Axillary pain, Breast pain, Burning sensation, Condition aggravated
Clinical narrative: Body aches and pain; swollen, painful lymph nodes. Left breast and left arm pit severe. Cardiac dysrhythmia, bounding pulse. (Dx: frequent PAC's and PVC's. Now taking Metoprolol succ ER 12.5 mg daily). Scar from surgery 3-8-2021 swollen, reddened, painful, burning, itching.(ongoing). Healing of surgery site WNL prior to COVID-19 vaccine.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram ambulatory, Erythema, Itching scar, Lymph node pain
Clinical narrative: Body aches and pain; swollen, painful lymph nodes. Left breast and left arm pit severe. Cardiac dysrhythmia, bounding pulse. (Dx: frequent PAC's and PVC's. Now taking Metoprolol succ ER 12.5 mg daily). Scar from surgery 3-8-2021 swollen, reddened, painful, burning, itching.(ongoing). Healing of surgery site WNL prior to COVID-19 vaccine.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Lymphadenopathy, Pain, Pulse abnormal, Scar pain, Supraventricular extrasystoles
Clinical narrative: Body aches and pain; swollen, painful lymph nodes. Left breast and left arm pit severe. Cardiac dysrhythmia, bounding pulse. (Dx: frequent PAC's and PVC's. Now taking Metoprolol succ ER 12.5 mg daily). Scar from surgery 3-8-2021 swollen, reddened, painful, burning, itching.(ongoing). Healing of surgery site WNL prior to COVID-19 vaccine.
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Swelling, Ventricular extrasystoles
Clinical narrative: Body aches and pain; swollen, painful lymph nodes. Left breast and left arm pit severe. Cardiac dysrhythmia, bounding pulse. (Dx: frequent PAC's and PVC's. Now taking Metoprolol succ ER 12.5 mg daily). Scar from surgery 3-8-2021 swollen, reddened, painful, burning, itching.(ongoing). Healing of surgery site WNL prior to COVID-19 vaccine.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Seizure, Seizure like phenomena, Syncope, Tremor
Clinical narrative: Patient received 2nd dose around 2:54 pm 04/28/2022. The patient fainted in her chair and her hands started shaking as if she was having a seizure. The episode lasted about 1-2 minutes. She regained conssciousness then fainted again about a minute later. 911 was called immediately after patient began seizing the first time. The patient regained consciousness about a minute or 2 after the second episode and remained stable until EMS arrived. EMS took the patient's vitals and they were good 02 sat 99% and blood pressure 110/67. The patient began feeling better and refused to go to the hospital after her vitals were obtained.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram cerebral abnormal, Blood glucose increased, Blood magnesium normal, Blood thyroid stimulating hormone normal, Computerised tomogram abnormal
Clinical narrative: Sudden onset vertigo.  Went to primary care physician.  Was able to replicate vertigo.  whenever I turned my head from left to right, while on back, room started spinning from left to right, top to bottom. I has also seen a neurologist a few days before, and an opthalmologist the week before, both for routine exams and they didn't see anything wrong with their exams.  My Primary Care Physician sent me to the emergency department for a CAT scan to rule out posterior stroke.  At the ED they gave me the CT scan but the radiologist said I also needed an MRA which they did.  No evidence of posterior stroke.  ED doctor discharged me with prescription for meclizine and valium.  Told me to do employ maneuvers.  If vertigo continues, consider vestibular physical therapy.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Full blood count, Metabolic function test, Vertigo, Vertigo positional
Clinical narrative: Sudden onset vertigo.  Went to primary care physician.  Was able to replicate vertigo.  whenever I turned my head from left to right, while on back, room started spinning from left to right, top to bottom. I has also seen a neurologist a few days before, and an opthalmologist the week before, both for routine exams and they didn't see anything wrong with their exams.  My Primary Care Physician sent me to the emergency department for a CAT scan to rule out posterior stroke.  At the ED they gave me the CT scan but the radiologist said I also needed an MRA which they did.  No evidence of posterior stroke.  ED doctor discharged me with prescription for meclizine and valium.  Told me to do employ maneuvers.  If vertigo continues, consider vestibular physical therapy.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Depressed level of consciousness, Feeling cold, Hyperhidrosis, Hypoacusis, Hypophagia
Clinical narrative: Client was present in the clinic for her booster dose of Pfizer (Lot # FM0698), received to her LD at 1825. At 1830, the client?s mother alerted observation staff to attend to her daughter. The client presented with diaphoresis and pallor, reported changes to her vision and hearing, and appeared to have experienced a slight decrease in her LOC; answering questions only after much prompting. She was able to transfer to a WC and laid down on the cot at 1832. Her BP at 1834 was 106/64 laying, HR was 67, SPO2 was 98% on RA. No s/s respiratory distress was noted. Shortly after lying down, the client stated that she felt ?fine, now that I?m laying down? and reported that she only remembered receiving her vaccination and none of the events that followed immediately afterward. She was carefully assessed for s/s of an allergic/anaphylactic reaction. None were noted.  VS at 1840 were: BP 108/62 laying, HR 88, SPO2 100% on RA. The client c/o feeling shaky at 1841. She reported that she had only had a pretzel and a smoothie to eat for the entire day (and the smoothie was consumed after working out), but denied any history of vasovagal reactions. Juice and water were provided and consumed. She was also given a cover to help retain body heat. Shortly after consuming the juice, she reported that she felt better. At 1847, she was laughing and telling stories to her mother, who was at bedside. At 1854, she reported that she felt ?better. 95% normal? though she added that she was still feeling a little shaky. She was alert and oriented, responding appropriately to questions. No further diaphoresis was noted and her pallor had resolved. She denied further dizziness or hearing/vision changes. She continued to show no s/s of an allergic reaction. Her BP at 1857 was 112/64 laying, HR was 90, SPO2 was 99% on RA.  At 1859, she sat at the edge of the cot without assistance, reported that she felt ?okay? and denied any increased dizziness, vision/hearing changes. Her BP sitting was 108/70, her HR was 65, and her SPO2 was 99% RA. She remained sitting without difficulty. At 1902, she stood at the edge of the cot, BP was 108/66, HR was 78, SPO2 was 99% RA. She reported that she felt ?normal, but cold? noting that the vent was blowing directly on her.  She and her mother were educated on vasovagal reactions, what s/s to watch for, and when to seek medical care. They both verbalized understanding. She was also encouraged to report this reaction to her medical professionals the next time she presents for a procedure involving needles and to be sure to have adequate PO intake beforehand. Her mother reports that she will be home with her family and they will monitor her condition throughout the evening. The client was able to stand and walk without difficulty. She and her mother settled in observation for a few more minutes and exited the facility at 1916.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness, Pallor, Visual impairment
Clinical narrative: Client was present in the clinic for her booster dose of Pfizer (Lot # FM0698), received to her LD at 1825. At 1830, the client?s mother alerted observation staff to attend to her daughter. The client presented with diaphoresis and pallor, reported changes to her vision and hearing, and appeared to have experienced a slight decrease in her LOC; answering questions only after much prompting. She was able to transfer to a WC and laid down on the cot at 1832. Her BP at 1834 was 106/64 laying, HR was 67, SPO2 was 98% on RA. No s/s respiratory distress was noted. Shortly after lying down, the client stated that she felt ?fine, now that I?m laying down? and reported that she only remembered receiving her vaccination and none of the events that followed immediately afterward. She was carefully assessed for s/s of an allergic/anaphylactic reaction. None were noted.  VS at 1840 were: BP 108/62 laying, HR 88, SPO2 100% on RA. The client c/o feeling shaky at 1841. She reported that she had only had a pretzel and a smoothie to eat for the entire day (and the smoothie was consumed after working out), but denied any history of vasovagal reactions. Juice and water were provided and consumed. She was also given a cover to help retain body heat. Shortly after consuming the juice, she reported that she felt better. At 1847, she was laughing and telling stories to her mother, who was at bedside. At 1854, she reported that she felt ?better. 95% normal? though she added that she was still feeling a little shaky. She was alert and oriented, responding appropriately to questions. No further diaphoresis was noted and her pallor had resolved. She denied further dizziness or hearing/vision changes. She continued to show no s/s of an allergic reaction. Her BP at 1857 was 112/64 laying, HR was 90, SPO2 was 99% on RA.  At 1859, she sat at the edge of the cot without assistance, reported that she felt ?okay? and denied any increased dizziness, vision/hearing changes. Her BP sitting was 108/70, her HR was 65, and her SPO2 was 99% RA. She remained sitting without difficulty. At 1902, she stood at the edge of the cot, BP was 108/66, HR was 78, SPO2 was 99% RA. She reported that she felt ?normal, but cold? noting that the vent was blowing directly on her.  She and her mother were educated on vasovagal reactions, what s/s to watch for, and when to seek medical care. They both verbalized understanding. She was also encouraged to report this reaction to her medical professionals the next time she presents for a procedure involving needles and to be sure to have adequate PO intake beforehand. Her mother reports that she will be home with her family and they will monitor her condition throughout the evening. The client was able to stand and walk without difficulty. She and her mother settled in observation for a few more minutes and exited the facility at 1916.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Muscle strength abnormal, Pain in extremity
Clinical narrative: Patient states that pain occurred in left arm the day after receiving the vaccine and the arm pain has not improved after over a month. She also notices reduction in range of motion and muscle strength in her left arm as well.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Injected limb mobility decreased, Injection site pain
Clinical narrative: Injection site pain lasting four days. Decrease in mobility of right arm lasting four days due to pain.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Nausea, Pyrexia
Clinical narrative: Patient presented at the vaccination site on 01/06/2022. She reported receipt of the first dose of Pfizer COVID-19 vaccine on 01/12/2021 (batch/lot# EK4176). The next morning she went to ER for nausea, dizziness, fever, chills and severe headache (8/10 on a pain scale of 10). She was told these were normal reactions by ER MD and sent home with instruction to take Tylenol. She took Tylenol every eight hours for two days straight for fever and headache. She denied shortness of breath for both first and second dose of Pfizer COVID vaccine (02/02/2021; batch/lot# EL3302). No anaphylactic symptoms. She did not follow-up with her PCP. She has no chronic illnesses, taking any medications; nor any known allergy. She requested the booster dose of Pfizer COVID-19 vaccine today. Submitted a medical consult via text message to clinical project coordinator requesting to proceed with the booster dose of Pfizer COVID-19 vaccine. At 1700, per the doctor, approval to proceed with the booster dose of Pfizer COVID-19 vaccine obtained via text message from the clinical project coordinator. Today, the booster dose of Pfizer COVID-19 vaccine was not administered to client since client left the vaccination site before she received her approval. Called client's cell and left a message she received approval to come any day to the vaccination site is open to get her booster dose of Pfizer COVID-19 vaccine.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: SHE DEVELOPED SWELLEN LYMPH NODES AFTE 24 HOURS. PER MD IS SUBCLEVICAL LYMPH NODES . SHE HAS BEEN USING ICE PACKS   IT HAS BEEN GETTING AFTER TIME BY STILL SOME SWELLEN
Age: 65.0
Sex: F
Vaccine: PNC20
Symptoms: Cellulitis, Erythema, Local reaction, Peripheral swelling
Clinical narrative: left arm redness and swelling, treated initially for cellulitis but not responding to antibiotics, more likely local injection reaction
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody increased, Autonomic nervous system imbalance, Blood test, Cardiac stress test normal, Dizziness
Clinical narrative: 11/30/21 - Received Pfizer booster shot. Sore at injection site 12/01/21 - Low grade fever, body aches, fatigue. These lasted for 2 days. Mild fatigue continued to last 12/06/21 - Sore throat and fatigue and dizziness, heart palpitations, and vasovagal syncope and pre syncope episodes begin. The sore throat lasted for over 2 weeks. Fatigue and dizziness has been continuous. Vasovagal syncope episodes continued to last for 1.5 months. I saw near vasovagal syncope episodes because I took steps to make sure I did not faint. For example, if I saw my vision was dimming/blackening, I would quickly sit or lie down. 12/27/21 - Extreme dizziness started, it is constant. Fatigue is getting worse.  Both symptoms continue until present time 1/10/22 - Tension headaches begin Present time - fatigue, dizziness, autonomic disorder, tension headaches, heart palpitations, exercise and heat intolerance, postural lightheadedness , diagnosed with Postural orthostatic tachycardia syndrome
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram normal, Electrocardiogram ambulatory normal, Electrocardiogram normal, Exercise tolerance decreased, Fatigue
Clinical narrative: 11/30/21 - Received Pfizer booster shot. Sore at injection site 12/01/21 - Low grade fever, body aches, fatigue. These lasted for 2 days. Mild fatigue continued to last 12/06/21 - Sore throat and fatigue and dizziness, heart palpitations, and vasovagal syncope and pre syncope episodes begin. The sore throat lasted for over 2 weeks. Fatigue and dizziness has been continuous. Vasovagal syncope episodes continued to last for 1.5 months. I saw near vasovagal syncope episodes because I took steps to make sure I did not faint. For example, if I saw my vision was dimming/blackening, I would quickly sit or lie down. 12/27/21 - Extreme dizziness started, it is constant. Fatigue is getting worse.  Both symptoms continue until present time 1/10/22 - Tension headaches begin Present time - fatigue, dizziness, autonomic disorder, tension headaches, heart palpitations, exercise and heat intolerance, postural lightheadedness , diagnosed with Postural orthostatic tachycardia syndrome
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Laboratory test, Magnetic resonance imaging head normal, Magnetic resonance imaging neck, Mononucleosis heterophile test positive
Clinical narrative: 11/30/21 - Received Pfizer booster shot. Sore at injection site 12/01/21 - Low grade fever, body aches, fatigue. These lasted for 2 days. Mild fatigue continued to last 12/06/21 - Sore throat and fatigue and dizziness, heart palpitations, and vasovagal syncope and pre syncope episodes begin. The sore throat lasted for over 2 weeks. Fatigue and dizziness has been continuous. Vasovagal syncope episodes continued to last for 1.5 months. I saw near vasovagal syncope episodes because I took steps to make sure I did not faint. For example, if I saw my vision was dimming/blackening, I would quickly sit or lie down. 12/27/21 - Extreme dizziness started, it is constant. Fatigue is getting worse.  Both symptoms continue until present time 1/10/22 - Tension headaches begin Present time - fatigue, dizziness, autonomic disorder, tension headaches, heart palpitations, exercise and heat intolerance, postural lightheadedness , diagnosed with Postural orthostatic tachycardia syndrome
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Palpitations, Postural orthostatic tachycardia syndrome, Presyncope
Clinical narrative: 11/30/21 - Received Pfizer booster shot. Sore at injection site 12/01/21 - Low grade fever, body aches, fatigue. These lasted for 2 days. Mild fatigue continued to last 12/06/21 - Sore throat and fatigue and dizziness, heart palpitations, and vasovagal syncope and pre syncope episodes begin. The sore throat lasted for over 2 weeks. Fatigue and dizziness has been continuous. Vasovagal syncope episodes continued to last for 1.5 months. I saw near vasovagal syncope episodes because I took steps to make sure I did not faint. For example, if I saw my vision was dimming/blackening, I would quickly sit or lie down. 12/27/21 - Extreme dizziness started, it is constant. Fatigue is getting worse.  Both symptoms continue until present time 1/10/22 - Tension headaches begin Present time - fatigue, dizziness, autonomic disorder, tension headaches, heart palpitations, exercise and heat intolerance, postural lightheadedness , diagnosed with Postural orthostatic tachycardia syndrome
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory syncytial virus test negative, SARS-CoV-2 test negative, Streptococcus test negative, Supraventricular extrasystoles
Clinical narrative: 11/30/21 - Received Pfizer booster shot. Sore at injection site 12/01/21 - Low grade fever, body aches, fatigue. These lasted for 2 days. Mild fatigue continued to last 12/06/21 - Sore throat and fatigue and dizziness, heart palpitations, and vasovagal syncope and pre syncope episodes begin. The sore throat lasted for over 2 weeks. Fatigue and dizziness has been continuous. Vasovagal syncope episodes continued to last for 1.5 months. I saw near vasovagal syncope episodes because I took steps to make sure I did not faint. For example, if I saw my vision was dimming/blackening, I would quickly sit or lie down. 12/27/21 - Extreme dizziness started, it is constant. Fatigue is getting worse.  Both symptoms continue until present time 1/10/22 - Tension headaches begin Present time - fatigue, dizziness, autonomic disorder, tension headaches, heart palpitations, exercise and heat intolerance, postural lightheadedness , diagnosed with Postural orthostatic tachycardia syndrome
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Temperature intolerance, Tension headache, Tilt table test positive, Ventricular extrasystoles
Clinical narrative: 11/30/21 - Received Pfizer booster shot. Sore at injection site 12/01/21 - Low grade fever, body aches, fatigue. These lasted for 2 days. Mild fatigue continued to last 12/06/21 - Sore throat and fatigue and dizziness, heart palpitations, and vasovagal syncope and pre syncope episodes begin. The sore throat lasted for over 2 weeks. Fatigue and dizziness has been continuous. Vasovagal syncope episodes continued to last for 1.5 months. I saw near vasovagal syncope episodes because I took steps to make sure I did not faint. For example, if I saw my vision was dimming/blackening, I would quickly sit or lie down. 12/27/21 - Extreme dizziness started, it is constant. Fatigue is getting worse.  Both symptoms continue until present time 1/10/22 - Tension headaches begin Present time - fatigue, dizziness, autonomic disorder, tension headaches, heart palpitations, exercise and heat intolerance, postural lightheadedness , diagnosed with Postural orthostatic tachycardia syndrome
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac tamponade, Chest X-ray abnormal, Dyspnoea, Dyspnoea exertional, Echocardiogram abnormal
Clinical narrative: Vaccine booster given on 11/1/2021. Muscle aching noted the next day.  The days following I began to become winded doing things as simple as normal walking.  The feeling of being winded continued and worsened by the day until I went to the Emergency Room during the early morning hours of 11/9/2021.  I was transferred by ambulance from there to the  Medical Center in Emergency Room to see cardiology.  I had flown from 11/4 to 11/8.   I was diagnosed by cardiology as having pericarditis.  I was sent to the cardiac cath lab to remove the fluid.  1075 cc's of fluid was removed from my heart.  My cardiologist said that my heart had gone into cardiac tamponade during the procedure.  I was moved to the ICU after the procedure and then discharged home the next day.  I was placed on preventative meds on discharge.  In follow-up chest imaging, it was determined that I also had a small pulmonary embolus that showed in my right lung.  The cardiologist said it appeared to be older and likely from when the pericarditis was.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Intensive care, Myalgia, Pericardial drainage, Pericarditis, Pulmonary embolism
Clinical narrative: Vaccine booster given on 11/1/2021. Muscle aching noted the next day.  The days following I began to become winded doing things as simple as normal walking.  The feeling of being winded continued and worsened by the day until I went to the Emergency Room during the early morning hours of 11/9/2021.  I was transferred by ambulance from there to the  Medical Center in Emergency Room to see cardiology.  I had flown from 11/4 to 11/8.   I was diagnosed by cardiology as having pericarditis.  I was sent to the cardiac cath lab to remove the fluid.  1075 cc's of fluid was removed from my heart.  My cardiologist said that my heart had gone into cardiac tamponade during the procedure.  I was moved to the ICU after the procedure and then discharged home the next day.  I was placed on preventative meds on discharge.  In follow-up chest imaging, it was determined that I also had a small pulmonary embolus that showed in my right lung.  The cardiologist said it appeared to be older and likely from when the pericarditis was.